Stories > GSK Upgraded, Silo Pharma Analysis

GSK Upgraded, Silo Pharma Analysis

Biogen's Q3 Report and Reata Acquisition

Biotech Deal: Roivant and Roche

Biotech Downturn and Funding Challenges

ABIO ARCA Revenue Analysis

ADR Surge and Drops in NY

AHF Criticizes Gilead Sciences for Profi...